[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584997":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":19,"locations":26,"responsibleParty":44,"collaborators":7,"id":48,"slug":7,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":7,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":7,"overallStatus":66,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DRUG","Tenofovir Disoproxil Fumarate (TDF)","ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION",[14,17],{"name":15,"affiliation":5,"role":16},"Effat AbdelHady Tony Ahmed, PROFESSOR OF NEPHROLOGY","STUDY_DIRECTOR",{"name":18,"affiliation":5,"role":16},"Mohamed Abdelhakim Omran Mahdy, LECTRURER",[20],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"NOUR SHAABAN MOHAMED, RESIDENT OF NEPHROLOGY","CONTACT","01122193390","01116123320","nour.20124438@med.aun.edu.eg",[27],{"facility":28,"status":7,"city":29,"state":7,"zip":7,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Faculty of Medicine","Asyut","Egypt","EG",{"type":33,"coordinates":34},"Point",[35,36],31.18368,27.18096,{"lat":36,"lon":35},[39],{"name":40,"role":22,"phone":41,"phoneExt":42,"email":43},"NOUR SHAABAN MOHAMED, RESIDENT","+0201122193390","+0201116123320","NOUR.20124438@MED.AUN.EDU.EG",{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Nour shaaban Mohamed Abd elrasoul","Principal Investigator","100584997",false,"NCT06896630","Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B","Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B","Inclusion Criteria:\n\nAdult male or female patients aged 18 to 60 years.\n\nDiagnosed as HBV-positive.\n\nLong-term use of Tenofovir Disoproxil Fumarate (TDF) for more than five years.\n\nExclusion Criteria:\n\nPresence of other chronic liver diseases.\n\nDiagnosed with Chronic Kidney Disease (CKD), regardless of etiology.\n\nPatients who refuse to participate in the study.\n\nPatients on combination therapy, including:\n\nInterferon and Nucleoside analogue combination therapy.\n\nMultiple nucleoside analogue combination therapy.","ALL","18 Years","60 Years",{"count":58,"type":59},172,"ESTIMATED","OBSERVATIONAL","Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients with Chronic Hepatitis B Over a Five-Year Period",[63,64,65],"Tenofovir Disoproxil Fumarate","Renal Function Disorder","Chronic HBV Infection","NOT_YET_RECRUITING","2025-04-02",{"date":69,"type":70},"2025-04-04","ACTUAL",{"date":72,"type":59},"2025-04-10",{"date":74,"type":59},"2026-05-01",{"name":5,"class":6},1]